Medical Fair Asia 2022, Singapore

Medical Fair Asia 2022 was a momentous event for IntegriMedical. We introduced our ingenious product at the expo, showcasing our innovation and technological advancement in drug delivery solutions, parallel to none.

Read more@ https://integrimedical.com/medical-fair-asia-singapore

Comments

Post a Comment

Popular posts from this blog

Pune Startup Unveils Needle-free Injection Device

Image
  The device administers medication through the skin using a high-pressure, hair-fine jet, eliminating the need for traditional needles. Pune-based medtech startup IntegriMedical has unveiled a needle-free, spring-powered injection device aimed at making drug delivery safer and virtually painless. The device administers medication through the skin using a high-pressure, hair-fine jet, eliminating the need for traditional needles. Founded in 2020 by Sarvesh Mutha, Ankur Naik, Scott McFarland, and Mark Timm, the company seeks to address both patient needle phobia and healthcare worker safety risks. “Needle phobia is more than just fear—it can cause patients to skip life-saving treatments,” said Sarvesh Mutha, Managing Director, IntegriMedical. He added that the device also reduces the risk of needle-stick injuries and cross-contamination for healthcare professionals. The Needle-Free Injection System (N-FIS) uses a stainless-steel piston and a disposable cartrid...
Read more

Needle Free Drug Delivery System

 Multi-Fold Benefits of Needle-Free Drug Delivery System IntegriMedical’s needle-free drug delivery system is beneficial for patients as it offers a nearly painless injection process. Moreover, it is beneficial for healthcare professionals, as it eliminates needle-stick injuries and chances of cross-contamination. As there are no needles, there is no need for a special disposal system, making it eco-friendly as well. Read more@ https://integrimedical.com/ 
Read more

Serum Institute wants to advance needle-free injection tech so picked 20% in IntegriMedical

Serum Institute of India (SII) has picked a 20% stake in IntegriMedical as the company envisions a needle-free solution to deliver vaccines. Financial details were not disclosed.   SII CEO Adar Poonawalla said, "At SII, we are constantly seeking opportunities to invest in technologies that align with our mission to make healthcare accessible and affordable for people worldwide."   Speaking about IntegriMedical's US-patented Needle-Free Injection System (N-FIS), Poonawalla said it represents a significant advancement in drug delivery and could revolutionise the way vaccines are administered, making the process more comfortable for patients and healthcare professionals.   Read more@ https://www.cnbctv18.com/india/healthcare/serum-institute-picks-20-pc-stake-in-integrimedical-to-advance-needle-free-injection-technology-n-fis-19413473.htm
Read more